Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Nursing Students Connect Beyond the Classroom With ONS Resources
    Nursing education
    Nursing Students Connect Beyond the Classroom With ONS Resources
    March 05, 2021
    COVID-19 Affects Cancer Caregivers, but Here Are Ways to Support Them
    COVID-19
    COVID-19 Affects Cancer Caregivers, but Here Are Ways to Support Them
    February 19, 2021
    Celebrate Oncology Nurse Leaders During Black History Month
    ONS Leadership
    Celebrate Oncology Nurse Leaders During Black History Month
    February 03, 2021
    Am I Too Shy to Lead?
    Nurse staffing
    Am I Too Shy to Lead?
    January 29, 2021
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    nursing professional development
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    January 22, 2021
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Oral adherence

    We Need More Evidence to Assess Technologies for Oral Adherence
    Oral adherence

    We Need More Evidence to Assess Technologies for Oral Adherence

    Oral anticancer agents are often expensive, and ensuring that patients have the financial means to pay for the medication is the first important step to improving adherence rates. Each health system has a group of individuals, not technology, to manage access to financial assistance. Even if they can afford the therapy, however, patients often struggle to maintain oral adherence.

    November 05, 2020
    Educational Framework Offers Guidance for Oral Chemo Safety at Home
    Safety

    Educational Framework Offers Guidance for Oral Chemo Safety at Home

    One aspect that ambulatory oncology nurses must consider in the greater staffing conversation is the time spent on educating patients and caregivers about oral chemotherapy safety in the home setting. Developing an educational framework to guide those conversations not only ensures that all critical information is covered but also that it’s delivered in a standard and efficient process. 

    March 10, 2020
    The Case of the Efficacy Explanation
    Treatments

    The Case of the Efficacy Explanation

    Jenni is an oncology nurse practitioner in an outpatient medical oncology clinic. She is meeting with 70-year-old Don after his first cycle of cabozantinib for treatment of metastatic medullary thyroid carcinoma when he asks why the oncologist put him on a pill instead of using IV chemotherapy. “Is it because I don’t have long to live?” Don wonders.

    November 19, 2019
    Future of Nursing; Adults Ration Medication; Drug Parity Act
    Oncology nursing community

    Future of Nursing; Adults Ration Medication; Drug Parity Act

    It’s been almost a decade since the Institute of Medicine—now the National Academies of Medicine (NAM)—released The Future of Nursing: Leading Change, Advancing Health report. Although many aspects of the nursing profession have been enhanced, still others are woefully lacking in change. Healthcare workplace safety incidents are still too high—up to 12 times higher than in the overall workforce—educational opportunities are still too expensive, and scope-of-practice authority is still too limiting in many states—all of which are ONS policy priorities.

    March 25, 2019
    Which of the Following Strategies Is an Example of Developing a Provider-Patient Relationship to Negotiate an Oral Adherence Plan?
    Oncology nurse-patient relationship

    Which of the Following Strategies Is an Example of Developing a Provider-Patient Relationship to Negotiate an Oral Adherence Plan?

    A provider develops a partnership with a patient and negotiates behaviors to reach an agreement to adhere to oral chemotherapy medication. This is an example of which strategy?

    a. Reinforcement

    b. Operant conditioning

    c. Motivational interviewing

    d. Partnership   

    March 01, 2019
    ONS Tackles Oral Chemotherapy Complexities
    Oral adherence

    ONS Tackles Oral Chemotherapy Complexities

    To ensure that patients and providers are equipped with the latest, most up-to-date knowledge and resources, ONS routinely works with patient advocacy groups, subject matter experts, and other provider organizations to develop and refine critical information for clinical practice. Following safety standards and meeting patient education requirements are critical to successful oral chemotherapy practice.

    November 06, 2018
    How Oncology Nurses Provide Quality Care Through Telephone Triage
    Oncology nurse-patient relationship

    How Oncology Nurses Provide Quality Care Through Telephone Triage

    As a direct line to the oncology team, the phone conversations between nurses and their patients can help address symptoms, foster valuable patient education, provide useful interventions, encourage side effect reporting, and identify potentially life-threatening situations. Ultimately, successful telephone triage requires a unique skill set for oncology nurses to communicate with their patients and recognize underlying issues.

    November 06, 2018
    Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 2
    Oral adherence

    Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 2

    This is the third in a series detailing some of the general factors to consider around patient adherence to oral medications, and ways to support patients receiving neratinib.

    October 26, 2018
    Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 1
    Oral adherence

    Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 1

    This is the third in a series detailing some of the general factors to consider around patient adherence to oral medications, and ways to support patients receiving neratinib.

    October 26, 2018
    Oral Adherence With Nerlynx® (Neratinib) Tablets: Patient Case
    Oral adherence

    Oral Adherence With Nerlynx® (Neratinib) Tablets: Patient Case

    AS is a 58-year-old woman who was diagnosed at age 55 with a right infiltrating ductal carcinoma of the breast, identified as grade III, ER and PR positive, and HER2 positive. She had bilateral mastectomy, and tumor size was noted to be 2.8 cm. She had a positive sentinel lymph node. She was staged at IIB (pT2, pN1, M0). Her left breast was noted to have usual ductal epithelial hyperplasia and a 1.2 cm fibroadenoma. AS’s genetic testing revealed a BRCA1 mutation (BRCA1 c.3748G>T [p.Glu1250*]), which may confer an increased risk for breast cancer in the range of 46%–87%, and 39%–63% risk for ovarian cancer by age 70. As her patient history shows, she has some risk factors for nonadherence, including no support at home and some financial issues. Throughout her care, the team worked to communicate and prepare AS to help ensure adherence as much as possible.

    October 26, 2018
    Oral Adherence With Nerlynx® (Neratinib) Tablets: Introduction
    Oral adherence

    Oral Adherence With Nerlynx® (Neratinib) Tablets: Introduction

    The cancer treatment landscape has shifted with the emergence of new, targeted therapies. Development and use of oral oncolytics, targeted cancer therapies that can be taken by patients orally in their own homes, has increased in recent years. This increase is due in part to research in extra- and intracellular signaling pathways. By interfering with or blocking these signals, targeted drugs have become standard agents in cancer therapy. Oral oncolytics currently account for about 25% of the oncology pipeline of drugs in clinical development, and experts project that oral oncoloytic use will continue to rise.

    October 26, 2018
    Care Coordination Standardizes Monitoring for Patients Prescribed Oral Cancer Agents
    Oral adherence

    Care Coordination Standardizes Monitoring for Patients Prescribed Oral Cancer Agents

    Use of oral therapies requires healthcare teams to monitor patients for issues such as unreported side effects, medication nonadherence, and incorrect administration of medications. Although many patients do very well with this form of treatment, some patients, even with a significant amount of education before starting therapy, may have challenges. 

    August 20, 2018
    How APRNs Can Support Patients During Oral Agent Treatment
    Advanced practice nursing (APN)

    How APRNs Can Support Patients During Oral Agent Treatment

    Oral agents offer many patient benefits, one of which is the freedom to take the medication at home, allowing them to keep their daily routine and gain additional time and independence they would have spent traveling to the clinic for treatment. However, with that freedom comes additional patient responsibilities, and preparation from advanced practice RNs (APRNs) is necessary to ensure patients can self-manage symptoms and adhere to administration regimens. Research shows that patients experience severe symptoms on oral agents that may cause them to miss as many as one-third of the prescribed doses. How can APRNs empower patients to adhere to the treatment plan and ensure safe symptom self-management at home? 

    August 16, 2018
    Communication, Organization Are Top Drivers of Oral Adherence in Clinical Trials
    Oral adherence

    Communication, Organization Are Top Drivers of Oral Adherence in Clinical Trials

    Oncology nurses know the challenges of patient adherence to oral cancer therapies. Every dose a patient misses can affect their outcomes and chance of survival. But in clinical trials, oral adherence has even broader implications: when a study is evaluating the efficacy of a drug, it depends on study participants taking it exactly as the trial outlines.

    July 10, 2018
    ASCO Annual Meeting

    Study Investigates How Health Literacy Affects Adherence to Oral Cancer Medications

    Ensuring patients adhere to oral medications for cancer can be a complex task, especially if patients have low health literacy. Oral medications for cancer continue to be more prevalent, but rates of adherence to oral therapy vary widely by population, cancer type, and level of education. At the 2018 American Society of Clinical Oncology Annual Meeting, researchers presented the results of a study that hypothesized health literacy’s connection to oral medication adherence and whether a multilevel intervention approach would result in greater adherence.

    June 04, 2018
    How Are You Tracking Patients on Oral Chemotherapy?
    Chemotherapy

    How Are You Tracking Patients on Oral Chemotherapy?

    Oral cancer treatments are effective and practical and can provide a level of flexibility for patients, allowing them to seamlessly continue their treatments without the burden of infusion visits. With many patients receiving oral chemotherapy, oncology nurses must recognize complications that can arise regarding procedure and documentation in practice.  

    December 29, 2017
    Oncology Nurse Advisor Navigation Summit

    Tackling Adherence as More Oral Therapies Come to Market

    As many as 25%–30% of all new antineoplastic agents in development are estimated to be oral, and almost half of the 300 medications in phase II and III clinical trials are oral medications. A paradigm shift is taking place in chemotherapy delivery. During a session at the Oncology Nurse Advisor Navigation Summit, ONS member Jan Tipton, MSN, RN, AOCN®, at the University of Toledo Medical Center in Ohio, discussed how cancer is making a shift to oral medications.

    June 16, 2017
    An oncology nurse promotes oral adherence
    Oral adherence

    Oncology Nurses Can Use Evidence to Promote Oral Adherence

    Administration of chemotherapy drugs has shifted dramatically in the past 15 years from parenteral to oral administration. This change requires patients to self-manage their chemotherapy. Patients need to understand important medication administration tasks: right dose, right time, right route, and right drug.
    January 05, 2016
    Oncology nurses help patients adhere to oral chemotherapy
    Oral adherence

    How Can Nurses Help Patients Adhere to Their Oral Chemotherapy?

    Oral chemotherapy, like IV chemotherapy, effectively helps patients fight cancer and may have similar side effects to its IV counterparts. Self-administration of oral chemotherapy may be convenient, but it is still chemotherapy and requires extra caution.
    January 05, 2016
    Improving ahderence to oral treatment plans
    Oral adherence

    Adherence to Oral Agents for Cancer

    Adherence to oral agents for cancer (OACs) is an important issue in the oncology setting. Unlike IV agents, which are typically administered in a controlled environment by oncology nurses, OACs are self-administered at home with little professional oversight. The potential for medication error or nonadherence cannot be underestimated, but oncology nurses are in a key position to spearhead initiatives aimed at improving patient education and adherence for OACs.
    January 05, 2016
    Cancer treatments

    Understand Medication Adherence to Oral Oncology Agents

    More than half of new cancer treatment regimens involve an oral route of administration because oral drugs are more manageable and convenient for patients. However, oral medications pose challenges with regard to patient adherence.
    April 25, 2015
    Oncology nurse monitoring oral oncolytics
    Clinical practice

    Reference Tool Helps Nurses Monitor Patients Receiving Oral Oncolytics

    As the use of oral oncolytics has increased in cancer care, so has the amount of time oncology nurses spend educating and counseling patients and caregivers on their use. Studies have shown that although it’s challenging for nurses to carve out, the time is well spent.
    November 11, 2014
    Oral chemotherapy administration safety
    Chemotherapy

    U.S. Survey Reports Oral Chemotherapy Practice and Safety Patterns

    As chemotherapy administration has shifted from IV delivery in the infusion center to oral delivery at home, so has the burden for the five rights of medication administration.
    March 11, 2014
    Understanding safe handling of oral agents
    Oral adherence

    No Ordinary Pill

    Oral agents are changing oncology treatment, and along with it, who’s responsible for the safety of those treatments. “With oral agents, the onus is now primarily on patients and their caregivers,” says ONS member Kathy Leifeste. This is quite a shift from the nurse-administered IV chemotherapy and biotherapy we’ve grown accustomed to.
    March 01, 2014
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    • Oncology nurse influence
    View All Topics
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2021 Oncology Nursing Society
     
    Back to Top ▲